Following the deaths of around 20 children linked to contaminated Coldrif cough syrup, the Directorate General of Health Services has issued a stringent advisory to all states and Union Territories, directing them to enforce stricter testing protocols for pharmaceutical products. The regulator emphasised the urgent need for thorough batch testing of both raw materials and finished products, adherence to safety norms under the Drugs Rules, and sourcing ingredients exclusively from approved vendors.
